Equity strategies

FP Carmignac European Leaders

OEICEuropean market
Share Class

GB00BJHPHZ49

A high-conviction, bottom-up European Ex-UK Equity strategy
  • An investment process seeking profitable companies with attractive long-term prospects, built on robust fundamentals and strong business models
  • A high-conviction, low turnover, concentrated portfolio designed to maximise long-term alpha generation
  • A socially responsible approach which includes negative screening, ESG criteria integration, and a low carbon emission approach
Asset Allocation
Equities96.8 %
Other3.2 %
Data as of:  31 Jul 2025.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
+ 80.4 %
-
+ 30.3 %
+ 25.8 %
- 2.4 %
From 15/05/2019
To 18/08/2025
Calendar Year Performance 2024
-
-
-
-
+ 18.2 %
+ 27.1 %
+ 13.9 %
- 14.8 %
+ 13.9 %
+ 6.8 %
Net Asset Value
1.80 £
Asset Under Management
109 M £
Net Equity Exposure31/07/2025
96.8 %
Data as of:  18 Aug 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

FP Carmignac European Leaders fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  31 Jul 2025.
Fund management team
[Management Team] [Author] Denham Mark

Mark Denham

Head of Equities, Fund Manager

Market environment

  • In July, the most significant development was the breakthrough trade agreement between the European Union and the United States which left most imports subject to a 15% tariff rate.

  • Although these new tariff rates are significantly higher than before Trump’s presidency, equity markets responded positively to the fact that the new agreements reduce the risk of an escalating trade war.

  • The Magnificent Seven companies continued to report stronger earnings growth, while European technology heavyweights issued cautious statements regarding the potential negative impact of US trade policy on their 2026 growth targets.

Performance commentary

  • In July, the fund delivered a positive absolute return though below its comparator benchmark.

  • Healthcare was a drag on performance, primarily due to Novo Nordisk issuing a profit warning and revising down its sales and earnings outlook due to softer-than-expected U.S. growth for its key drugs.

  • The Financials sector also underperformed relative to our benchmark.

  • That said, UBS, a recent addition to the portfolio, delivered a strong Q2. Earnings more than doubled year-over-year, supported by robust revenue growth in both Investment Banking and Global Wealth Management.

  • The Industrials sector which we reinforced in the recent months was the biggest relative contributor.

  • Prysmian continued its strong momentum, capitalizing on robust demand in electrification and digital infrastructure. The company posted strong Q2 results with solid organic growth and margins.

Outlook strategy

  • During the month of July, we added a new position to our portfolio, Flatexdegiro, which complements our existing holdings in B2C platforms Nordnet and Fineco, providing us with additional exposure to the increasing penetration of the European savings market.

  • However, we modestly trimmed our positions in Prysmian and Kion which performed extremely well in the recent weeks.

  • We maintain relatively low exposure at around 93% as we aim to use any price weakness to add to existing names exposed to potential strong domestic German and European economic growth.

  • The Fund continues to rely on bottom-up fundamental analysis with a medium-to-long-term horizon.

  • We remain committed to our philosophy and believe this is a great opportunity for our investors to gain access to some of Europe’s best companies at attractive entry valuations.

Performance Overview

Data as of:  18 Aug 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Source: Carmignac at 19/08/2025

FP Carmignac European Leaders Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  31 Jul 2025.
Europe100.0 %
View details

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  31 Jul 2025.
Equity Investment Weight96.8 %
Net Equity Exposure96.8 %
Number of Equity Issuers47
Active Share75.7 %

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Manager.
Fund Management Team
[Management Team] [Author] Denham Mark

Mark Denham

Head of Equities, Fund Manager
In our approach to European equities, we focus on sustainable high-quality companies which demonstrate high levels of profitability while favoring profits reinvestment over profits distribution to grow the business for the future.
View Fund's characteristics

Articles that may interest you

European equities14 July 2025English

FP Carmignac European Leaders: Letter from the Fund Manager - Q2 2025

3 minute(s) read
Find out more
European equities7 July 2025English

Banking on (non-traditional) financials

5 minute(s) read
Find out more
European equities4 July 2025English

Mark Denham named Best Alpha Manager by Fundinfo

1 minute(s) read
Find out more
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
​The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performance is shown net of fees (excluding any subscription fees payable to the distributor). Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.